Invention Grant
US08703141B2 Method for treating Crohn's disease by administering an anti-IL-12 antibody
有权
通过施用抗IL-12抗体治疗克罗恩病的方法
- Patent Title: Method for treating Crohn's disease by administering an anti-IL-12 antibody
- Patent Title (中): 通过施用抗IL-12抗体治疗克罗恩病的方法
-
Application No.: US13670918Application Date: 2012-11-07
-
Publication No.: US08703141B2Publication Date: 2014-04-22
- Inventor: Jill Giles-Komar , David M. Knight , David Peritt , Bernard Scallon , David Shealy
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agent Eric Dichter
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders, such as Crohn's disease.
Public/Granted literature
- US20130064760A1 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody Public/Granted day:2013-03-14
Information query
